Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
Serpe
L
L
Department of Anatomy, Pharmacology and Forensic Medicine, University of Torino, Torino, Italy. loredana.serpe@unito.it
Catalano
M G
MG
Cavalli
R
R
Ugazio
E
E
Bosco
O
O
Canaparo
R
R
Muntoni
E
E
Frairia
R
R
Gasco
M R
MR
Eandi
M
M
Zara
G P
GP
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity; D020148:Butyric Acid / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002788:Cholesterol Esters / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D019073:HT29 Cells; D006801:Humans; D049329:Nanostructures / Q000633:toxicity*
D000970:Antineoplastic Agents; D002788:Cholesterol Esters; D020148:Butyric Acid